# Long-Term Follow Up of VOY-101 Non-nAMD Extension Study

> **NCT07660640** · — · ENROLLING_BY_INVITATION · sponsor: **Perceive Biotherapeutics, Inc.** · enrollment: 88 (estimated)

## Conditions studied

- Age-Related Macular Degeneration (AMD)
- Non-Neovascular Age-Related Macular Degeneration

## Interventions

- **OTHER:** observational study
- **BIOLOGICAL:** VOY-101

## Key facts

- **NCT ID:** NCT07660640
- **Lead sponsor:** Perceive Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-03-03
- **Primary completion:** 2031-07-30
- **Final completion:** 2031-08-30
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660640, "Long-Term Follow Up of VOY-101 Non-nAMD Extension Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*